Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital
Phoenix, Arizona, United States
Recruiting - Sarcoma Oncology Research Center (sorc) Cancer Center of Southern California
Santa Monica, California, United States
Recruiting - Mayo Clinic Hospital
Jacksonville, Florida, United States
Recruiting - Mayo Clinic
Rochester, Minnesota, United States
Recruiting - Washington University
St Louis, Missouri, United States
Recruiting - Rutgers Cancer Institute of New Jersey 195 Little Albany Street New Brunswick, Nj 08901 Room 2031
New Brunswick, New Jersey, United States
Recruiting - Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Recruiting - Seattle Cancer Care Alliance 825 Eastlake Ave. E. Seattle, Wa 98109 Mail Stop Ce2-128
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Dec 2018
- Primary completion
- 31 Dec 2024
- Completion
- 31 Dec 2025
- Last update posted
- 10 Oct 2023
- Registered enrollment
- 114
- Registry id
- NCT03420014
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.